We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
October 27 - Hedge Funds, News
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
September 7 - Hedge Funds, News
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Keep Reading →
July 13 - Hedge Funds, News
In this article we will take a look at whether hedge funds think Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) is a good investment right now.
Keep Reading →
June 3 - Hedge Funds, News
We hate to say this but, we told you so.
Keep Reading →
April 7 - Hedge Funds, News
Is Momenta Pharmaceuticals, Inc.
Keep Reading →
December 10 - Hedge Funds, News
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through October 17th.
Keep Reading →
October 27 - Hedge Funds, News
How do we determine whether Momenta Pharmaceuticals, Inc.
Keep Reading →
May 3 - Hedge Funds, News
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Keep Reading →
December 17 - Hedge Funds, News
Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish factories.
Keep Reading →
February 22 - News, Stock Analysis
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money...
Keep Reading →
December 7 - Hedge Funds, News
It's a little-known fact that stock performance is not evenly distributed (i.e. you don't have a 50/50 chance of picking a market-beating stock).
Keep Reading →
November 30 - Hedge Funds, News
Jacob Gottlieb’s Visium Asset Management, Richard Gerson and Navroz D.
Keep Reading →
April 29 - Hedge Funds, News
Steven Cohen has continued into the spring cleaning of his equity portfolio, reducing stakes in several stocks.
Keep Reading →
April 7 - Hedge Funds, News
Steven Cohen’s SAC Capital Advisors has reported adding Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) to its equity portfolio.
Keep Reading →
March 13 - Hedge Funds, News
To many of your peers, hedge funds are viewed as useless, old investment tools of an era lost to time.
Keep Reading →
September 11 - News
Now, according to many market players, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times.
Keep Reading →
September 4 - News
To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
Keep Reading →
September 3 - News
If you were to ask many of your fellow readers, hedge funds are seen as useless, old investment tools of a forgotten age.
Keep Reading →
September 3 - News
In the 21st century investor’s toolkit, there are dozens of methods shareholders can use to monitor their holdings.
Keep Reading →
August 27 - News
To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time.
Keep Reading →
August 25 - News
The investing waters can get pretty choppy from time to time with a developmental stage company. A look at the five-year chart of Momenta Pharmaceuticals, Inc.
Keep Reading →
August 2 - News
It isn't very often that an agency sometimes accused of over-regulating an industry can be ridiculed for not regulating enough, but that's exactly where the Food and Drug Administration...
Keep Reading →
August 2 - News
The United States Court of Appeals is making this one miserable summer for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).
Keep Reading →
July 29 - News
At the moment, there are dozens of methods investors can use to monitor the equity markets. Some of the most useful are hedge fund and insider trading interest.
Keep Reading →
July 5 - News
Love it or hate it, the Patient Protection and Affordable Care Act -- commonly referred to as Obamacare -- changes the health care landscape.
Keep Reading →
July 5 - News
It's understandably very tempting for people with inside information to trade biotech stocks.
Keep Reading →
June 17 - News
Generic-drug makers are always on the hunt for the next branded drug to take down.
Keep Reading →
June 13 - News
If you'd ask most investors, hedge funds are viewed as unimportant, old financial tools of yesteryear.
Keep Reading →
June 10 - News
In the 21st century investor’s toolkit, there are tons of indicators shareholders can use to monitor stocks.
Keep Reading →
June 10 - News
In the 21st century investor’s toolkit, there are dozens of indicators shareholders can use to track Mr. Market.
Keep Reading →
June 6 - News
Everyone loves owning dividend stocks. They may not drive your investment strategy, but you sure don't mind getting paid just to own a company.
Keep Reading →
May 30 - News
Earlier this month, Baxter International Inc. (NYSE:BAX) reported that the clinical trials for the treatment of Alzheimer’s disease (Gammagard) had failed.
Keep Reading →
May 29 - News
Take one look at the returns from biotech darlings Celgene Corporation (NASDAQ:CELG), Biogen Idec Inc. (NASDAQ:BIIB), and Gilead Sciences, Inc.
Keep Reading →
April 30 - News
Hi-Tech Pharmacal Co. (NASDAQ:HITK) was in 11 hedge funds' portfolio at the end of December.
Keep Reading →
April 10 - News
Is Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) an exceptional investment now? Prominent investors are buying.
Keep Reading →
April 8 - News
Despite its name, Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has been losing steam since the end of 2011 with revenue falling 97% in the last nine months.
Keep Reading →
February 5 - News
